Company Overview of Mission Pharmacal Company, Inc.
Mission Pharmacal Company, Inc., a pharmaceutical company, develops and manufactures prescription medications and over-the-counter products in therapeutic areas of women's health, pediatric, urology, and dermatology. The company’s products include CitraNatal, a prescription prenatal vitamin that provides nutrition for preconception, pregnancy, and lactation in various formulations customized for individual patient needs; Urocit-K, a potassium citrate indicated for the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of etiology, and uric acid lithiasis with or without calcium stones; Lithostat (acetohydroxamic acid) for use as an adjunc...
10999 Interstate Highway 10 West
San Antonio, TX 78230-1355
Founded in 1946
Key Executives for Mission Pharmacal Company, Inc.
President of Commercial Operations
Senior Director of Consumer Marketing
Compensation as of Fiscal Year 2016.
Mission Pharmacal Company, Inc. Key Developments
Mission Pharmacal Company Announces Availability of Lycelle Head Lice Removal Kit
May 18 16
Mission Pharmacal Company has announced the availability of the former prescription Lycelle Head Lice Removal Kit without a prescription. Lycelle is a treatment for the elimination of head lice and their eggs. Lycelle uses a non-pesticidal formulation that is safe for use with children as young as two years of age and is typically effective with just one 10 minute use. Lycelle is now available to consumers across the nation in retail and independent pharmacies. Each Lycelle Head Lice Removal Kit contains one 3.38 fl. oz. bottle of pre-combing gel and a single fine-toothed comb that is used to remove the lice and their eggs. Lycelle has a pleasant wintergreen scent and a brief application time, making treating young children a less-trying experience for both child and parent. Many other head lice treatments rely on pesticides that attack the lice's nervous system to kill the lice and, in some cases, their eggs.
Mission Pharmacal Receives FDA Approval for Liquid Potassium Iodide Oral Solution for Nuclear Emergency Management
May 17 16
Mission Pharmacal Company announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for over-the-counter liquid Potassium Iodide Oral Solution USP. The solution is a ready to use thyroid blocking medication that can be used by all ages in the event of a nuclear emergency. Although potassium iodide tablets are available, the FDA recommends a liquid oral solution for infants and small children because it allows for accurate and precise dosing. Potassium iodide works by saturating the thyroid, thereby preventing radioactive iodine from entering the organ. The sooner a person takes potassium iodide following exposure, the more effective the drug will be in preventing thyroid cancer, a health concern following nuclear radiation. Infants, children, and pregnant and nursing females are the most vulnerable to radiation poisoning. Mission Pharmacal Company plans to begin manufacturing its Potassium Iodide Oral Solution immediately.
Retrophin, Inc. and Mission Pharmacal Enter into a Third Amendment to Trademark License and Supply Agreement
Mar 24 16
Retrophin, Inc. and Mission Pharmacal Company are parties to that certain Trademark License and Supply Agreement, dated May 28, 2014, as amended, pursuant to which Mission has granted the Company an exclusive, royalty-bearing license to market, sell and commercialize Thiola and a non-exclusive license to use know-how relating to Thiola to the extent necessary to market Thiola. On March 23, 2016, the Company and Mission entered into a Third Amendment to Trademark License and Supply Agreement pursuant to which the Company and Mission agreed to amend the Supply Agreement to, among other things, include a new formulation development project for tiopronin tablets.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|